Members

Blog Posts

黑五美亞直郵入手LACOSTE休閑船鞋

Posted by 时尚潮人 on May 24, 2022 at 4:46am 0 Comments

作為一個標準的漢子,雙11剁手剁的比傢裡LD還誇張,快遞收到公司門衛大叔都不送上來給我瞭,叫我自己去拿,所以想著今年黑五就堅決不買瞭,可是色魔張大媽還是剁吾手不止,硬是強推瞭這麼一條,還特麼偏偏讓我看到瞭。



樓主其實是一個輕度法鱷迷,自初中的時候老爸從香港給樓主帶瞭一條Lacoste Polo 衫就喜歡上這個牌子瞭,雖然不是大牌,但是價格也是蠻結棍的。不過質量還真的很不錯,一件大學時買的polo衫現在還在穿,還不過時,起碼7,8年瞭,這樣想想性價比還是很高的。 LACOSTE的色彩運用很大膽,顏色怎麼跳就怎麼來,偏偏各種大老爺們兒穿上還很好看。所以樓主基本上有去奧萊或者手癢心也癢的時候就會買點LACOSTE的東西,要忍住,畢竟價格也不是白菜啊。



這次張大媽推的這個真的是要瞭親命瞭,抱著必死的決心下的單。按照LD的說法,你的鞋都可以每周換著穿都不帶重樣的瞭,還買!樓主內心:你丫的鞋每天換著穿都不帶重樣的有啥資格說我。… Continue

LACOSTE、Cartelo、Crocodile,究竟哪個是真鱷魚?

Posted by 时尚潮人 on May 24, 2022 at 4:45am 0 Comments

與“鱷魚”有關的品牌在國內隨處可見,最知名的有三個,常常讓人混淆,究竟哪一個是正宗的呢?今天小編給大傢詳細講一講。

LACOSTE



一、LACOSTE(法國鱷魚)

品牌由來:



1927年,法國網球選手René Lacoste與同他一起被稱作網球“四劍客”的隊友一起,第一次從美國人手中奪得瞭戴維斯杯,從而開始瞭他的網壇傳奇生涯,在1928年他又續寫瞭這項成績。當時,René Lacoste為自己設計並命人縫制瞭一批透氣舒適的針織棉襯衫。它們的吸汗效果特別好,非常適合在炎熱的美國球場上穿著。馬上,這種襯衫就在網球選手間掀起瞭一場革命,因為當時他們還穿著用普通佈制作的傳統長袖襯衫在場上比賽。



一次戴維斯杯比賽中,當時的法國隊隊長AllanH.Muhr打賭說,如果René… Continue

Botox & Dysport injections for wrinkles - Botox

Posted by Mcquiston Tammi on May 24, 2022 at 4:45am 0 Comments

As the name itself suggests, the SoftLift ™ produces a rested and Visit the website lifted look. A natural looking result has all to do with the competence of the injector. Our group of licensed Clinical Physicians and also Registered Nurses have actually dealt with over 1 million people over the last decade with SoftLift ™. Lip fillers are a fantastic way to attain fuller, smoother as well as a lot…

Continue

Vitiligo Treatment Market Key Growth Factors, Detailed Present Scenario and Growth Prospects 2027

Vitiligo is a skin condition characterized by white patches on the skin. The patches are a result of the loss of melanocytes. The global vitiligo treatment market report by Market Research Future (MRFR) contains useful drivers, challenges, and insights for the period of 2019 to 2025 (forecast period). The effects of the COVID-19 pandemic on the production of skin pigmentation drugs and other medicines have been included in the report with a special emphasis on each region.

The global Vitiligo Treatment Market Size can swell up to USD 1.84 billion by 2025. It is expected to showcase a CAGR of 5.6% CAGR during the forecast period. Huge prevalence of vitiligo is one of the primary drivers of the market. This is exemplified by the treatment of close to 150,000 Americans in the U.S. Investments in healthcare infrastructure by developing and developed economies can influence the market.

Changes in lifestyles and awareness of the skin condition among the populace can bode well for the market. Development of new therapies and treatment and focus on external appearances will fuel treatment demand. For instance, researchers at the University of Massachusetts Medical School have developed a targeted therapy which can remove the cells responsible for causing vitiligo. The approval of this treatment can revolutionize the industry.

Get Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/8442

Segmentation

The global vitiligo treatment market is segmented by type, treatment type, and end user.

By Type, it is divided into segmental vitiligo and nonsegmental vitiligo.
By Treatment Type, it is segmented into surgery, medication, and therapy. The medication segment is projected to drive the market growth over the forecast period due to approval of the latest drugs by federal regulation bodies. Low cost of treatment compared to others is one of the biggest growth drivers of the segment.
By End user, it is segmented into aesthetic clinics, hospitals & clinics, and others. Hospitals & clinics are expected to dominate the market during the forecast period. This can be attributed to the preference of these healthcare facilities by patients as the primary point of care.
Competition Outlook

Eli Lilly Company, Astellas Pharma Inc., STRATA Skin Sciences, Clinuvel Pharmaceuticals Limited, Baxter International Inc., Novartis AG, AstraZeneca AB, Reddy’s Laboratories Ltd., Pfizer Inc., Bausch Health Companies Inc., Allergan, Inc., Incyte Corporation, and Epizyme, Inc. are major players in the global vitiligo treatment market.

Regional Analysis

Europe, Americas, the Middle East & Africa (MEA), and Asia Pacific (APAC) are major regions of focus in the global vitiligo treatment market.

The Americas are predicted to lead the global vitiligo treatment market due to a rise in research and development and increasing willingness of healthcare providers in giving treatment. Focus on development of targeted therapy for vitiligo and immunosuppressants can bode well for the region.

Get Access Full Report @ https://www.marketresearchfuture.com/reports/vitiligo-treatment-mar...

On the other hand, APAC is likely to display the fastest growth rate during the forecast period owing to government initiatives, surge in healthcare spending, and a large patient pool. Rise in the number of funds for expediting the treatment for vitiligo can bolster the market demand at a significant rate.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future (MRFR) team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York, New York 10013,

United States of America

+1 646 845 9312

Email: [email protected]

Views: 1

Comment

You need to be a member of On Feet Nation to add comments!

Join On Feet Nation

© 2022   Created by PH the vintage.   Powered by

Badges  |  Report an Issue  |  Terms of Service